Clinical Trials Directory

Trials / Completed

CompletedNCT00819871

Nuclear Factor Kappa-B (NFKB1) Polymorphism and Organ Injury After Cardiac Surgery

Association of NFKB1 -94 Polymorphism With Lung and/or Kidney Injury After Cardiac Surgery With Cardiopulmonary Bypass

Status
Completed
Phase
Study type
Observational
Enrollment
105 (actual)
Sponsor
Changhai Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

NFKB1 -94ins/del polymorphism has been reported to be associated with reduced promoter activity of NFKB1 and several clinical diseases, but the clinical results cannot always be replicated. Besides, mutate allele is associated with alleviated inflammation in ulcerative colitis and some tumors, but aggravated inflammation in ARDS. The clinical value of this polymorphism remains controversial. This study was performed to investigate the association of NFKB1 -94ins/delATTG polymorphism with lung and/or kidney injury after cardiac surgery with CPB.

Conditions

Timeline

Start date
2008-05-01
Primary completion
2008-10-01
Completion
2008-12-01
First posted
2009-01-09
Last updated
2013-05-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT00819871. Inclusion in this directory is not an endorsement.